@article{3c569e80e39443b491711d4556fb99c2,
title = "Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens",
author = "Abhishek Maiti and Rausch, {Caitlin R.} and Cortes, {Jorge E.} and Naveen Pemmaraju and Daver, {Naval G.} and Farhad Ravandi and Guillermo Garcia-Manero and Gautam Borthakur and Kiran Naqvi and Maro Ohanian and Short, {Nicholas J.} and Yesid Alvarado and Kadia, {Tapan M.} and Koichi Takahashi and Musa Yilmaz and Nitin Jain and Steven Kornblau and Guillermo Montalban-Bravo and Koji Sasaki and Michael Andreeff and Prithviraj Bose and Alessandra Ferrajoli and Issa, {Ghayas C.} and Jabbour, {Elias J.} and Lucia Masarova and Thompson, {Philip A.} and Sa Wang and Sergej Konoplev and Pierce, {Sherry A.} and Jing Ning and Wei Qiao and Welch, {John S.} and Kantarjian, {Hagop M.} and DiNardo, {Courtney D.} and Konopleva, {Marina Y.}",
note = "Funding Information: Funding: this study was supported in part by the MD Anderson Cancer Center Support Grant CA016672 from the National Cancer Institute, and Research Project Grant Program (R01CA235622) from the National Institutes of Health.",
year = "2021",
month = mar,
doi = "10.3324/haematol.2020.252569",
language = "English (US)",
volume = "106",
pages = "894--898",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "3",
}